"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
48,"no","yes","The Role of Adiposity in Cardiometabolic Traits: A
Mendelian Randomization Analysis",2013,"PLOS Medicine","10.1371/journal.pmed.1001474","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","The association between adiposity and cardiometabolic traits is well known from epidemiological studies. Whilst the causal relationship is clear for some of these traits, for others it is not.","one-sample meta-analysis","cholesterol","total cholesterol","metabolic","Not discussed","Current study","18+","Both",147619,NA,NA,NA,NA,"Healthy","European","BMI","BMI","Current study","18+","Both",147619,NA,NA,"Healthy","European","Age, Sex","Whenever rs9939609 was not genotyped directly, we used either (i) the HapMap II CEU (European) reference panel–imputed genetic information from genome-wide association studies (http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2008-10_phaseII/) for rs9939609 (n = 5) or (ii) genotype information from a predefined list of proxies that are in high linkage disequilibrium (LD) with rs9939609 (n = 10, r2>0.9; Table S3)",NA,"Not discussed","Not discussed",NA,"R2 > 0.9","p>0.0001","FTO (rs9939609)",NA,NA,NA,NA,"No",NA,"Inverse variance weighted (multiplicative random effects)","Not discussed",NA,NA,NA,NA,"Observational estimates were similar","Not discussed","Varied by cohort but  at least one cohort used PLINK, R, SPSS, STATA","Not discussed","Not discussed","Not discussed","No","kg/m2","mmol/l","beta","6.0000000000000001E-3",NA,95,-0.018,0.03,"0.63","None",NA,"The limitations of our study are tied to the validity of the assumptions underlying causal interpretation within MR studies.","the precise mechanism of the FTO polymorphisms is still unclear, and potential pleiotropy cannot completely be ruled out","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely","Post hoc power calculation showed that for the binary traits with non-significant IVs (CHD, ischemic stroke, and all-cause stroke), we had an 80% chance of detecting an IV estimator odds ratio (OR) of 1.08–1.09/BMI unit or higher, and a 95% chance of detecting an OR of 1.13–1.15/BMI unit or higher.",NA,765
164,"no","yes","Type 2 Diabetes and Adiposity Induce Different Lipid Profile Disorders: A Mendelian Randomization Analysis",2018,"The Journal of Clinical Endocrinology and Metabolism","10.1210/jc.2017-02789","Wang","Yingli Lu","luyingli2008@126.com","Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011","Effect of body mass index on lipids","Type 2 diabetes and obesity often coexist, so it is difficult to judge whether diabetes or obesity induce certain types of hyperlipidemia due to mutual confounds and reverse causation","One-sample","cholesterol","total cholesterol","metabolic","TG, TC, HDL-C, and LDL-C were measured with a Beckman Coulter AU680","Current study","18-93","both",9798,NA,NA,NA,NA,"Healthy","Chinese","BMI","BMI","Wen 2012 Body mass index East asian both","18-93","both",9798,"unclear","One-sample","Healthy","East Asian","age, sex, BMI, hypertension, economic status","Not discussed","Not discussed","Tested association with confounders","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,14,13,"Additional SNP from Okada et al Nat Genet. 2012;44(3):302–306.","Not discussed",NA,"Wald ratio","Re-ran analysis with subset of SNPs",NA,NA,NA,NA,"Consistent with main analysis","F statistic = 39","SPSS","Not discussed","Not discussed","Not discussed","Not discussed","SD","mmol/L","beta","-9.0999999999999998E-2",NA,95,-1.071,0.889,"Not discussed",NA,NA,"The lipid profiles were measured only once at baseline. Hence, we were not able to control for intra- individual variability","It was difficult to use the GRSs to completely discriminate the effects of diabetes and obesity from the effects of other risk factors on changes in lipid profile because of the possible pleiotropic effects of SNPs, especially regarding the BMI_GRS","All of the participants were of Asian origin. Therefore, findings may not be applicable to other ethnicities.","Built our GRSs based only on common variants that are considered to represent limited diabetes and BMI heritability. We were unable to assess the po- tential contribution of rare variants.",NA,1892
